DAIC

MARCH 1, 2024

Food and Drug Administration ( FDA ) approval for the AGENT Drug-Coated Balloon (DCB), which is indicated to treat coronary in-stent restenosis (ISR) in patients with coronary artery disease. ISR is the obstruction or narrowing of a stented vessel by plaque or scar tissue. Boston Scientific plans to launch the technology in the U.S.

Stents 105

Stents Stent Coronary Artery Disease Angioplasty 105

DAIC

JULY 2, 2024

mtaschetta-millane Tue, 07/02/2024 - 09:45 July 2, 2024 — Biotronik announced the availability of an expanded Maximum Allowed Diameters (MAD) range for the Orsiro Mission Drug Eluting Stent (DES). Diameters 2.25 mm to 3.00 mm of the Orsiro Mission DES can now be extended up to 4.0mm, while diameters 3.5 mm and 4.0 mm can reach up to 5.0

Stents 105

Stents Stent Anatomy Technology 105

DAIC

JUNE 18, 2024

The designation recognizes the novelty of the technology and the potential to provide a more effective treatment option for patients with coronary artery disease. 1 To date, interventional treatment of coronary artery disease with drug-eluting stents has been able to establish flow angiographically. Food and Drug Administration (FDA).

Coronary Artery Disease 105

Coronary Artery Disease Technology Stents Stent 105

CardiacWire

MARCH 29, 2025

With the FDA nod, Abbott can now evaluate the IVL system in treating severe calcification in coronary arteries prior to stenting. Abbotts new IVL IDE was two years in the making following its $890M acquisition of Cardiovascular Systems in 2023 that gave the medtech giant an entry into the IVL arena.

Plaque 59

Plaque Interventional Cardiology Stents Stent 59

Frontiers in Cardiovascular Medicine

FEBRUARY 24, 2025

With the maturity of thoracic endovascular aortic repair (TEVAR) technology and its increasing application in clinical practice, complications and long-term management after TEVAR have become issues of concern. Imaging revealed the presence of an aortic abscess around the stent graft involving the esophagus and mediastinum.

Aortic 52

Aortic Stents Stent Hemorrhage 52

Society of Thoracic Surgeons - Technology

NOVEMBER 10, 2022

Webinar New FDA-Approved Aortic Technologies kchalko Thu, 11/10/2022 - 12:30 November 3, 2022 Recent approvals by the U.S. Food and Drug Administration (FDA) have made available two new technologies for treating aortic disease. Adult Cardiac Surgeon Technology Image

Technology 52

Technology Aortic Webinar Stents 52

DAIC

MAY 30, 2024

Clinical success was defined as optimal stent expansion after final treatment with no in-hospital major adverse cardiovascular event (MACE). stent expansion at Maximum Calcium Site 96.7% stent expansion at Maximum Calcium Site 96.7% Shown here: Elixir Medical CEO Motasim Sirhan.

Stents 105

Stents Stent Peripheral Arterial Disease Cardiovascular Disease 105

DAIC

JANUARY 29, 2024

Our one-of-a-kind comparison charts allow you to do a side-by-side review of the latest technologies and products from the industry’s leading vendors. TEVAR Stent Grafts 9. Here are links to the Top 10 viewed DAIC comparison charts from 2023: 1. Guidewires 2. Angiography Systems 3. Hemodynamic Monitoring Systems 4.

Interventional Cardiology 110

Interventional Cardiology Ultrasound Stents Stent 110

DAIC

APRIL 12, 2024

a pioneering medical technology company specializing in cardiovascular interventional devices, today announced that its groundbreaking Acolyte Image Guided Crossing and Re-Entry Catheter System has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration ( FDA ).

Technology 111

Technology Cardiovascular Interventions Coronary Artery Disease Innovation 111

Stroke Journal

FEBRUARY 1, 2024

In-silico evaluation (computer simulated analysis in a virtual stroke model) has the potential to test and optimize large number of stent-retriever design variations in a relatively time and cost-effective manner. Gravity Medical Technology’s SuperNova Stent-retriever was the device under investigation.

Stents 40

Stents Stent Blood Clot Anatomy 40

DAIC

MAY 6, 2024

milla1cf Mon, 05/06/2024 - 10:55 May 6, 2024 — SMT (Sahajanand Medical Technologies), a leading medical device company at the forefront of innovative patient care in the cardiovascular segment has announced a strategic partnership with HeartX , a pioneering MedTech company focused on research and development.

Congenital 105

Congenital Innovation VSD Stents 105

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

In‐silico evaluation (computer simulated analysis in a virtual stroke model) has the potential to test and optimize large number of stent‐retriever design variations in a relatively time and cost‐effective manner. Further studies are required to better understand the scope and potential of this technology.

Stents 40

Stents Stent Blood Clot Anatomy 40

DAIC

MARCH 20, 2024

1 To qualify for a Breakthrough Device Designation, a device technology must address an unmet need and show that it has the potential to provide for more effective treatment of life-threatening diseases or irreversibly debilitating conditions. CLTI is associated with high rates of amputation and mortality as well as high care costs.1

Peripheral Arterial Disease 105

Peripheral Arterial Disease Innovation Technology Coronary Artery Disease 105

DAIC

JULY 11, 2024

R3 Vascular is a privately-held medical device company that develops a novel technology platform for the next generation of fully bioresorbable drug eluting sirolimus coated vascular scaffolds.

Peripheral Arterial Disease 105

Peripheral Arterial Disease Stents Stent Education 105

Frontiers in Cardiovascular Medicine

DECEMBER 13, 2024

The CT data of aorta were collected before operation, and the aorta was reconstructed by Mimics software and printed with 3D printing technology. The clinical data during hospitalization and follow-up were analyzed.ResultsAll the patients of CoA were successfully treated with percutaneous balloon dilatation covered stent implantation.

VSD 52

VSD Blood Pressure Stents Stent 52

DAIC

JANUARY 31, 2024

Along with these challenges, treatment options are expanding, increasingly including calcium modification prior to stent implantation.

Document 108

Document Interventional Cardiology Stents Stent 108

DAIC

FEBRUARY 14, 2024

Using multiple, serial, intravascular scaffolds, the patented FlexStep Technology combines flexibility with support to open clogged vessels and sustain healthy blood flow while accommodating tortuosity and skeletal movement.

Heart Attack 111

Heart Attack Heart attacks Peripheral Arterial Disease Ischemia 111

Frontiers in Cardiovascular Medicine

JANUARY 10, 2024

Introduction Imaging fusion technology is promising as it is radiation and contrast sparing. The combined and matched subgroups were pulmonary artery stenting (Stent PUL ), aorta angioplasty (Plasty AO ), pulmonary artery angioplasty (Plasty PUL ), or a combination of the latter two (Plasty). and 39.3% (Overall group), 49.3%

Congenital 59

Congenital Angioplasty Congenital Heart Disease Stents 59

Frontiers in Cardiovascular Medicine

FEBRUARY 27, 2024

Deep learning also assisted in surgical procedures by accurately predicting stent placement and postoperative complications. Conclusion Deep learning technologies show remarkable potential in enhancing the diagnosis, treatment, and management of AA.

Aneurysm 59

Aneurysm Aortic Stents Stent 59

Frontiers in Cardiovascular Medicine

JANUARY 28, 2025

IntroductionThe accuracy of fenestrations in stent grafts for complex aortic aneurysms and dissections can be significantly improved using three-dimensional (3D)-printed phantoms. Standardization is enhanced by using artificial intelligence (AI) for image pre-processing before 3D printing.

Aneurysm 52

Aneurysm Aortic Stents Stent 52

ADN Center of Excellence

SEPTEMBER 27, 2023

Why IVUS and OCT Are Vital These technologies aren't just extras; they are the ticket to enhanced diagnostic accuracy and improved patient results. IVUS reveals plaque characteristics, optimal stent usage, and vessel measurements. This powerful duo empowers cardiologists to make well-informed choices.

Education 52

Education Best Practices Stents Stent 52

All About Cardiovascular System and Disorders

FEBRUARY 17, 2024

3D rotational angiography is not that old technique, but a novel technology which can create a volumetric data set of contrast-enhanced CT like images with excellent visualization of soft tissues and airway, with spatial resolution even better than multi-detector CT or cardiac magnetic resonance imaging [1].

Congenital Heart Disease 52

Congenital Heart Disease Congenital Aneurysm Heart Disease 52

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

3 The third‐generation iteration of the Pipeline Embolization Device (PED) incorporates Shield technology, a phosphorylcholine coating designed to reduce thrombogenicity via mimicry of native cell membranes.4 IntroductionIndications for flow diversion for the treatment of cerebral aneurysms have increased remarkably in recent years.1

Embolism 40

Embolism Aneurysm Hemorrhage Stents 40

ADN Center of Excellence

OCTOBER 14, 2024

In today’s fast-paced medical world, keeping up with the latest techniques and technologies is no longer a luxury for healthcare professionals it’s a necessity. ADN CoE is committed to fostering this innovation by integrating cutting-edge technology and evidence-based practices into all our hands-on training programs.

Innovation 59

Innovation Technology Anatomy Stents 59

Stroke: Vascular and Interventional Neurology

JANUARY 4, 2024

Endovascular devices have catalyzed a global industry for advanced technologies such as flow diverters and stent retrievers. Stroke: Vascular and Interventional Neurology, Ahead of Print.

Stents 40

Stents Stent Article Technology 40

Dr. S. Venkatesan MD

FEBRUARY 29, 2024

Fibro-Optic real shape( FORS) technology , which reconstructs image from optical data, and beam live fluro- like images, in 3 dimension. Here comes the real Innovation. May be, we may soon, say good bye to electrons, protons, and welcome these harmless photons.

Ultrasound 52

Ultrasound Anatomy Stents Stent 52

ADN Center of Excellence

OCTOBER 14, 2024

In today’s fast-paced medical world, keeping up with the latest techniques and technologies is no longer a luxury for healthcare professionals it’s a necessity. ADN CoE is committed to fostering this innovation by integrating cutting-edge technology and evidence-based practices into all our hands-on training programs.

Innovation 52

Innovation Technology Anatomy Stents 52

Dr. Smith's ECG Blog

JANUARY 1, 2013

The OM-1 was opened and stented, then the LAD was stented 3 days later. The LAD had a 75% proximal lesion that by fractional flow reserve was hemodynamically significant. So there was 3-vessel disease, but with an acute posterior STEMI. The acute infarct-related artery was off the circumflex and the affected wall was posterior (STEMI).

STEMI 52

STEMI Ischemia Chest Pain Myocardial Infarction 52

Dr. Smith's ECG Blog

MARCH 28, 2017

It was stented. Wall motion abnormalities are very hard to see, even with advanced Speckle Tracking technology. Regional wall motion abnormality-distal septum and apex. She was treated medically for NonSTEMI, pending next day cath, which showed ulcerated plaque and a 60% thrombotic stenosis in the LAD distal to the first diagonal.

STEMI 40

STEMI Risk Factors Bicuspid/Mitral Ultrasound 40

DAIC

JUNE 4, 2024

This new system combines a truly innovative stent design,” said Dr. Ramaiah, a former director of the Arizona Heart Hospital. “We We were fortunate to be the first in the Southwest to use such technology.” She already has three stents in her heart and so many stents and replacement arteries in both her legs that she’s lost count.

Stents 111

Stents Stent Research Strokes 111

Society of Thoracic Surgeons - Allied Health

FEBRUARY 14, 2023

Leveraging Technology to Improve CABG Outcomes Viviany Taqueti, MD, MPH (Boston, MA, USA) 9:20 a.m. External Stenting for Saphenous Vein Grafts in Coronary Surgery: A Systematic Review and Meta-Analysis Giovanni Jr. The Next Generation of Coronary Revascularization Trials Mario Gaudino, MD, PhD (New York, NY, USA) 8:36 a.m.

Coronary Artery Bypass Graft 52

Coronary Artery Bypass Graft Atrial Fibrillation Outcomes Stents 52

DAIC

MARCH 28, 2025

v As cardiovascular disease (CVD) continues to rise globally, vi the need for advanced diagnostic technologies like cardiac CT angiography (CCTA) becomes increasingly critical. vii Similarly, recent increases in Medicare reimbursement rates for CCTA are a positive step towards making this technology more accessible.

Technology 59

Technology Coronary Artery Disease Atrial Fibrillation Medicare 59

Dr. Smith's ECG Blog

OCTOBER 23, 2022

It was stented. Wall motion abnormalities are very hard to see, even with advanced Speckle Tracking technology. Regional wall motion abnormality-distal septum and apex. She was treated medically for NonSTEMI, pending next day cath, which showed ulcerated plaque and a 60% thrombotic stenosis in the LAD distal to the first diagonal.

STEMI 40

STEMI Chest Pain Hospital Risk Factors 40

DAIC

MARCH 13, 2024

In an original investigation presented at the Cardiology Research Technology conference in Washington, D.C. suggest that the drug-coated balloon offers an effective treatment strategy for the management of coronary in-stent restenosis, or blockages recurring within previously placed stents.

Stents 116

Stents Stent Angioplasty Myocardial Infarction 116

DAIC

MAY 3, 2024

Clinical trials and innovative technology took center stage during the month of April, racking up some record number views. New Study Reveals 65 and Older Population Lowered Blood Pressure, Cholesterol and Weight Using Mobile Technology 2. Around 10% of Deaths from Coronary Stenting, Balloon Angioplasty are Preventable 9.

Angioplasty 105

Angioplasty Blood Pressure Heart Attack Heart attacks 105

DAIC

APRIL 23, 2024

milla1cf Tue, 04/23/2024 - 15:53 April 23, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest innovation in cardiac surgery, the Avalus Ultra valve. Surgical aortic valve replacement with a stented pericardial bioprosthesis: 5-year outcomes. February 18–21, 2024.

Aortic valve 111

Aortic valve Aortic Innovation Cardiothoracic 111

DAIC

JUNE 13, 2024

Getty Images milla1cf Thu, 06/13/2024 - 20:38 June 13, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest innovation in cardiac surgery, the Avalus Ultra valve. Surgical aortic valve replacement with a stented pericardial bioprosthesis: 5-year outcomes. February 18–21, 2024.

Aortic valve 109

Aortic valve Aortic Innovation Cardiothoracic 109